Ctt Pharmaceutical CEO Ryan Khouri buys $454 in shares

Ryan Khouri, CEO and a director of CTT Pharmaceutical Holdings Inc. (NASDAQ:CTTH), recently increased his stake in the company. On September 22, 2026, Khouri acquired 10,100 shares of CTT Pharmaceutical Holdings stock. The transaction totaled $454, with shares purchased at a price of $0.045 each. The purchase comes as the stock trades at $0.06, down roughly 6% year-to-date and 20% over the past six months. According to InvestingPro analysis, the company appears overvalued at current levels, with a Price/Book ratio of 86.81. InvestingPro Tips highlight that the company is not profitable over the last twelve months—one of 5 additional tips available to subscribers.

Following this purchase, Khouri directly holds 9,424,556 shares of CTT Pharmaceutical Holdings.